Lv5
926 积分 2024-10-22 加入
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025
7小时前
已关闭
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
7小时前
已完结
Non–Small Cell Lung Cancer, Version 4.2024
7小时前
已完结
Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts
12天前
已完结
Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the AJR Special Series on Imaging of Inflammation
15天前
已完结
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung Cancer
16天前
已完结
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
17天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
18天前
已完结
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
18天前
已完结
Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990–2021, with projections up to 2040: a global time-series analysis and modelling study
21天前
已关闭
皖公网安备34019202002308
